En Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era

Ann Intern Med. 2024 May;177(5):667-669. doi: 10.7326/M24-0256. Epub 2024 Apr 9.

Authors

Christopher Radcliffe¹, Camille N Kotton²

Affiliations

¹ Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts (C.R.).
² Transplant Infectious Disease and Compromised Host Program and Travelers' Advice and Immunization Center, Division of Infectious Diseases, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts (C.N.K.).

PMID: 38588541
DOI: 10.7326/M24-0256

No abstract available

Publication types

Editorial

MeSH terms

COVID-19* / epidemiology
COVID-19* / immunology
COVID-19* / prevention & control
Drug Prescriptions
Immunocompromised Host*
Pandemics*
Patient Education as Topic
Travel